Back to Trades
Davidson Matt
Chief Development OfficerDirectorCIK 0001741937
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Davidson Matt, Chief Development Officer, Director, has filed 2 SEC reports (2026), all concentrated in ADIAL PHARMACEUTICALS, INC. (ADIL), totaling $671.7K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Grant | $671.7K |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Other | $0 |
2 filings